Jun Zhu
Affiliations: | Pharmacy | University of South Carolina, Columbia, SC |
Google:
"Jun Zhu"Mean distance: 106866
Cross-listing: StructuralBiologyTree
Parents
Sign in to add mentor| Ikunobu Muramatsu | grad student | 1998 | Fukui Medical School |
| Linda P. Dwoskin | post-doc | 2000-2002 | University of Kentucky |
Children
Sign in to add trainee| Sarah E. Davis | grad student | University of South Carolina | |
| Matthew J. Strauss | grad student | 2016- | University of South Carolina |
| Adrian M. Gomez | grad student | 2014 | University of South Carolina |
| Narasimha Midde | grad student | 2014 | University of South Carolina |
| Pamela M. Quizon | grad student | 2014-2019 | University of South Carolina |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Davis SE, Cirincione AB, Jimenez-Torres AC, et al. (2023) The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases. International Journal of Molecular Sciences. 24 |
| Davis SE, Ferris MJ, Ananthan S, et al. (2022) . The Journal of Pharmacology and Experimental Therapeutics |
| Strauss MJ, Porter KD, Quizon PM, et al. (2022) Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. Plos One. 17: e0275182 |
| Zhu J, Quizon PM, Wang Y, et al. (2022) SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice. Neuropharmacology. 109239 |
| Davis S, Zhu J. (2022) Substance abuse and neurotransmission. Advances in Pharmacology (San Diego, Calif.). 93: 403-441 |
| Adeniran C, Yuan Y, Davis SE, et al. (2021) Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat. Acs Chemical Neuroscience |
| Quizon PM, Yuan Y, Zhu Y, et al. (2021) Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology |
| Strauss M, O'Donovan B, Ma Y, et al. (2020) [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Tat Protein. The Journal of Pharmacology and Experimental Therapeutics |
| Aksenova M, Sybrandt J, Cui B, et al. (2019) Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology |
| Sun WL, Quizon PM, Yuan Y, et al. (2019) Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport. Scientific Reports. 9: 3843 |